ClinicalTrials.Veeva

Menu

Visual Outcomes After Vivity Toric IOL Implantation

E

EVP Eye Care

Status

Terminated

Conditions

Refractive Assessment

Treatments

Other: Procedure: Vivity Toric IOL

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The purpose of this study is to evaluate patient satisfaction after bilateral implantation of Vivity Toric Extended Vision Intraocular lens and visual outcomes.

Full description

To evaluate and report outcomes including postoperative uncorrected visual acuity, postoperative best corrected visual acuity, postoperative refractive error, and IOL rotational stability after Vivity Toric Extended Vision intraocular lens (IOL) implantation.

Enrollment

4 patients

Sex

All

Ages

45+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Calculated lens power within study IOL range of 15.0 diopters to 25.0 diopters and toric range of T3 to T6
  • Willing and able to comprehend informed consent form and to complete 1 day and 3-4 month postoperative visit
  • Potential postoperative best corrected distance visual acuity of 20/20 or better in each eye based on medical opinion of investigator

Exclusion criteria

  • Ocular pathology or comorbidity that could reduce potential postoperative best corrected distance visual acuity
  • Ocular trauma or zonular weakness/instability
  • Diagnosis of glaucoma or high-risk glaucoma suspect
  • Previous refractive surgery
  • Unreliable preoperative biometry measurements
  • Severe dry eye or ocular surface disease

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

4 participants in 1 patient group

Vivity Toric IOL
Other group
Description:
Patients with cataract that had phacoemulsification and Vivity Toric IOL implantation.
Treatment:
Other: Procedure: Vivity Toric IOL

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems